Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-04-09 Sale | 2025-04-11 4:08 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 5,004 | $12.99 | $65,002 | 211,168 (Direct) | View |
| 2025-04-09 Sale | 2025-04-11 4:07 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 6,169 | $12.99 | $80,135 | 227,719 (Direct) | View |
| 2025-04-09 Sale | 2025-04-11 4:06 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 11,063 | $12.99 | $143,708 | 399,767 (Direct) | View |
| 2025-04-09 Sale | 2025-04-11 4:05 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 28,094 | $12.99 | $364,941 | 1,186,512 (Direct) | View |
| 2025-03-07 Sale | 2025-03-11 4:18 pm | Immunovant Inc. | IMVT | Fromkin Andrew J. Director | 8,000 | $19.6 | $156,769 | 91,913 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 4:06 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 2,055 | $20.86 | $42,867 | 357,353 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 4:05 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 2,814 | $20.86 | $58,700 | 321,952 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 4:04 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 15,439 | $20.86 | $322,058 | 948,786 (Direct) | View |
| 2025-01-22 Sale | 2025-01-24 4:23 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 2,195 | $23.59 | $51,780 | 139,991 (Direct) | View |
| 2025-01-22 Sale | 2025-01-24 4:22 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 2,657 | $23.59 | $62,679 | 132,314 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:07 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 2,383 | $23.83 | $56,782 | 359,408 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:05 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 2,298 | $23.83 | $54,757 | 324,766 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:04 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 8,767 | $23.83 | $208,900 | 964,225 (Direct) | View |
| 2025-01-13 Purchase | 2025-01-15 4:36 pm | Immunovant Inc. | IMVT | Roivant Sciences Ltd. Director 10% Owner | 16,845,010 | $20 | $336,900,200 | 96,650,341 (Direct) | View |
| 2025-01-08 Sale | 2025-01-10 4:12 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 4,105 | $24.1 | $98,931 | 327,064 (Direct) | View |
| 2025-01-08 Sale | 2025-01-10 4:11 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 5,105 | $24.1 | $123,031 | 972,992 (Direct) | View |
| 2024-12-02 Sale | 2024-12-04 4:22 pm | Immunovant Inc. | IMVT | Pande Atul Director | 7,750 | $28.54 | $221,185 | 106,663 (Indirect Direct) | View |
| 2024-12-02 Sale | 2024-12-04 4:20 pm | Immunovant Inc. | IMVT | Hughes Douglas J. Director | 5,425 | $28.54 | $154,830 | 119,585 (Direct) | View |
| 2024-11-20 Sale | 2024-11-22 4:12 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 3,650 | $25.45 | $92,893 | 319,228 (Direct) | View |
| 2024-11-20 Sale | 2024-11-22 4:11 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 3,353 | $25.45 | $85,334 | 361,791 (Direct) | View |
| 2024-11-20 Sale | 2024-11-22 4:09 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 4,174 | $25.45 | $106,228 | 331,169 (Direct) | View |
| 2024-11-20 Sale | 2024-11-22 4:08 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 16,692 | $25.45 | $424,811 | 978,097 (Direct) | View |
| 2024-10-23 Sale | 2024-10-25 4:25 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 4,361 | $29.53 | $128,780 | 322,878 (Direct) | View |
| 2024-10-23 Sale | 2024-10-25 4:23 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 3,189 | $29.53 | $94,171 | 134,971 (Direct) | View |
| 2024-10-23 Sale | 2024-10-25 4:21 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 2,740 | $29.53 | $80,912 | 142,186 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-04-01 Option Award | 2025-04-03 4:55 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Van Tuyl Christopher Chief Legal Officer | 122,318 | $0 | 232,274 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:53 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Gloria Melanie Chief Operating Officer | 183,478 | $0 | 293,434 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:51 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 183,478 | $0 | 323,469 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:50 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 244,637 | $0 | 376,951 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:48 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 214,058 | $0 | 536,010 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:46 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 640,215 | $0 | 1,589,001 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:44 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Pande Atul Director | 23,788 | $0 | 130,451 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:43 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Hughes Douglas J. Director | 23,788 | $0 | 143,373 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:41 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Fromkin Andrew J. Director | 23,788 | $0 | 115,701 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:39 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | MIGAUSKY GEORGE V Director | 23,788 | $0 | 144,851 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:37 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Torti Frank Director | 292,964 | $0 | 928,638 (Direct) | View |
| 2024-12-16 Option Award | 2024-12-18 5:02 pm | N/A 2034-12-16 | Immunovant Inc. | IMVT | Van Tuyl Christopher Chief Legal Officer | 247,402 | $0 | 247,402 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 5:15 pm | N/A 2034-11-18 | Immunovant Inc. | IMVT | Gloria Melanie Chief Operating Officer | 247,402 | $0 | 247,402 (Direct) | View |